Bovine and porcine heparins: different drugs with similar effects on human haemodialysis

• Published in: BMC research notes Vol. 6; no. 1; p. 230
• Main Authors: Tovar, Ana M F, Teixeira, Lisandra A C, Rembold, Simone M, Leite, Jr, Maurilo, Lugon, Jocemir R, Mourão, Paulo A S
• Format: Journal Article
• Language: English
• Published: England BioMed Central Ltd 13-06-2013; BioMed Central
• Subjects: Animals; Anticoagulants; Cattle; Comparative analysis; Drug dosages; Drug therapy; Drugs; Health aspects; Heart surgery; Hemodialysis; Heparin; Heparin - blood; Heparin - pharmacology; Humans; Magnetic Resonance Spectroscopy; Patients; Pharmaceutical Preparations; Pharmaceuticals; Renal Dialysis; Swine; Thrombosis; Rio de Janeiro Brazil
• ISSN: 1756-0500; 1756-0500
• DOI: 10.1186/1756-0500-6-230

Heparins from porcine and bovine intestinal mucosa differ in their structure and also in their effects on coagulation, thrombosis and bleeding. However, they are used as undistinguishable drugs.
We compared bovine and porcine intestinal heparin administered to patients undergoing a particular protocol of haemodialysis. We compared plasma concentrations of these two drugs and also evaluated how they affect patients and the dialyzer used.
Compared with porcine heparin, bovine heparin achieved only 76% of the maximum plasma concentration as IU mL⁻¹. This observation is consistent with the activities observed in the respective pharmaceutical preparations. When the plasma concentrations were expressed on weight basis, bovine heparin achieved a maximum concentration 1.5 fold higher than porcine heparin. The reduced anticoagulant activity and higher concentration, on weight basis, achieved in the plasma of patients under dialysis using bovine instead of porcine heparin did not affect significantly the patients or the dialyzer used. The heparin dose is still in a range, which confers security and safety to the patients.
Despite no apparent difference between bovine and porcine intestinal heparins in the haemodialysis practice, these two types of heparins should be used as distinct drugs due to their differences in structure and biological effects.
The reduced anticoagulant activity achieved in the plasma of patients under dialysis using bovine instead of porcine heparin did not affect significantly the patients or the dialyzer.